Drugs / hydrocholothiazide
last change Dec 2025 re-read 2 minutes ago

hydrocholothiazide

Developed for
hypertensive disorder
Investigated by
National Institute of Cardiology, Warsaw, Poland

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06275763 Oct 2023 → Dec 2025 hypertensive disorder National Institute of Cardiology, Warsaw, Poland Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hydrocholothiazide “Replacement of ineffective antihypertensive treatment based on 3 or more antihypertensive drugs (single or dual drug preparations) with a triple single pill combination (SPC)...” NCT06275763